This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Mirjam Schenk: Innovator in Dendritic Cell Research
Introduction
Mirjam Schenk is a prominent inventor based in Los Angeles, California. She has made significant contributions to the field of immunology, particularly in the generation of potent dendritic cells. Her innovative work has implications for cancer therapy and vaccine development.
Latest Patents
Mirjam Schenk holds a patent titled "Method for generating potent dendritic cells." This patent describes a process for generating highly potent dendritic cells in vivo or ex vivo by exposing precursor cells to an effective dose of IL-32. This advancement is crucial for enhancing immune responses in therapeutic applications.
Career Highlights
Schenk is affiliated with the University of California, where she conducts her research. Her work has garnered attention for its potential to revolutionize treatments in immunotherapy. With 1 patent to her name, she continues to push the boundaries of scientific understanding in her field.
Collaborations
One of her notable collaborators is Robert L Modlin, with whom she has worked on various research projects. Their partnership has contributed to the advancement of knowledge in dendritic cell biology.
Conclusion
Mirjam Schenk's innovative research and patent in dendritic cell generation highlight her role as a key figure in immunology. Her contributions are paving the way for future advancements in medical therapies.